1-171103834-A-G
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PM5PP3PP5_Moderate
The NM_001002294.3(FMO3):c.182A>G(p.Asn61Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,613,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N61K) has been classified as Pathogenic.
Frequency
Consequence
NM_001002294.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FMO3 | NM_001002294.3 | c.182A>G | p.Asn61Ser | missense_variant | Exon 3 of 9 | ENST00000367755.9 | NP_001002294.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151992Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251252Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135778
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461640Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727126
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151992Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74228
ClinVar
Submissions by phenotype
Trimethylaminuria Pathogenic:2Other:1
Variant summary: FMO3 c.182A>G (p.Asn61Ser) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251252 control chromosomes (gnomAD). c.182A>G has been reported in the literature in individuals affected with Trimethylaminuria who had another missense variant in trans that some ClinVar submitters have classified as pathogenic (Dolphin_2000). These data indicate that the variant may be associated with disease. Publications report experimental evidence evaluating an impact on protein function, finding a variant effect resulting in <10% of normal trimethylamine metabolism and NADPH binding affinity (Dolphin_2000, Yeung_2007, Gao_2017). The following publications have been ascertained in the context of this evaluation (PMID: 29116146, 31580948, 11191884, 17531949). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at